Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: Patient's choice"

George Woody, Douglas Bruce, P. Todd Korthuis, Sumedha Chhatre, Maureen Hillhouse, Petra Jacobs, James Sorensen, Andrew J. Saxon, Sabrina Poole, David Metzger, Walter Ling

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)e142-e143
JournalJournal of Acquired Immune Deficiency Syndromes
Volume67
Issue number5
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Woody, G., Bruce, D., Korthuis, P. T., Chhatre, S., Hillhouse, M., Jacobs, P., Sorensen, J., Saxon, A. J., Poole, S., Metzger, D., & Ling, W. (2014). Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: Patient's choice". Journal of Acquired Immune Deficiency Syndromes, 67(5), e142-e143. https://doi.org/10.1097/qai.0000000000000344